Growth Metrics

AC Immune (ACIU) EBT (2016 - 2025)

Historic EBT for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$19.8 million.

  • AC Immune's EBT fell 41210.51% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year decrease of 8959.59%. This contributed to the annual value of -$58.1 million for FY2024, which is 492.44% up from last year.
  • AC Immune's EBT amounted to -$19.8 million in Q3 2025, which was down 41210.51% from -$25.6 million recorded in Q2 2025.
  • AC Immune's 5-year EBT high stood at $6.4 million for Q3 2024, and its period low was -$25.6 million during Q2 2025.
  • Over the past 5 years, AC Immune's median EBT value was -$19.5 million (recorded in 2022), while the average stood at -$17.8 million.
  • Per our database at Business Quant, AC Immune's EBT soared by 13705.55% in 2024 and then tumbled by 41210.51% in 2025.
  • Over the past 5 years, AC Immune's EBT (Quarter) stood at -$23.1 million in 2021, then rose by 15.65% to -$19.5 million in 2022, then soared by 72.52% to -$5.3 million in 2023, then crashed by 237.18% to -$18.0 million in 2024, then fell by 9.95% to -$19.8 million in 2025.
  • Its EBT stands at -$19.8 million for Q3 2025, versus -$25.6 million for Q2 2025 and -$21.2 million for Q1 2025.